Advances in triterpene drug discovery
Trends in Pharmacological Sciences · 2024-11 · 45 (11) · 964-968
DOI: 10.1016/j.tips.2024.10.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2024-11. Verfasst von Zoë R Goddard und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Metabolism, John Innes Centre, Norwich Research Park, Colney Lane, Norwich NR4 7UH, UK. Hauptthemen laut MEDLINE: Triterpenes, Drug Discovery. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, John Innes Centre, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Metabolism, John Innes Centre, Norwich Research Park, Colney Lane, Norwich NR4 7UH, UK.
- School of Chemistry, Pharmacy, and Pharmacology, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK.
- Department of Biochemistry and Metabolism, John Innes Centre, Norwich Research Park, Colney Lane, Norwich NR4 7UH, UK. Electronic address: anne.osbourn@jic.ac.uk.
Förderung
- Wellcome Trust
- John Innes Centre
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Goddard, Z. R., Searcey, M., & Osbourn, A. (2024). Advances in triterpene drug discovery. Trends in Pharmacological Sciences, 45(11), 964-968. https://doi.org/10.1016/j.tips.2024.10.003
Vancouver
Goddard ZR, Searcey M, Osbourn A. Advances in triterpene drug discovery. Trends in Pharmacological Sciences. 2024;45(11):964-968. doi:10.1016/j.tips.2024.10.003
BibTeX
@article{Goddard2024,
author = {Goddard, Zoë R and Searcey, Mark and Osbourn, Anne},
title = {Advances in triterpene drug discovery},
journal = {Trends in Pharmacological Sciences},
year = {2024},
volume = {45},
number = {11},
pages = {964--968},
doi = {10.1016/j.tips.2024.10.003}
}
EUVIMED